Short answer

When designing or evaluating medical interventions for critical conditions, consider a dual approach that assesses both clinical efficacy and economic viability to ensure the most beneficial and sustainable solutions.

Field: Commercial Production
Source: Health Technology Assessment (2010)
Method: Randomised controlled trial with parallel economic evaluation
Sample: 180 participants
Evidence: Moderate effect

Extracorporeal membrane oxygenation (ECMO) offers a potentially life-saving intervention for severe adult respiratory failure, but its comparative effectiveness and cost-effectiveness against conventional ventilatory support require careful evaluation within a design project. This commercial production research insight is drawn from a 2010 study published in Health Technology Assessment. Using Randomised controlled trial with parallel economic evaluation with 180 participants, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing or evaluating medical interventions for critical conditions, consider a dual approach that assesses both clinical efficacy and economic viability to ensure the most beneficial and sustainable solutions.

Study

Commercial ProductionHigh ImpactModerate effect

ECMO vs. Conventional Ventilation: A Cost-Effectiveness Analysis for Severe Respiratory Failure

Health Technology Assessment · 2010

Key Findings

01The study aimed to compare the effectiveness and cost-effectiveness of ECMO versus conventional ventilation for severe respiratory failure.
02A total of 180 patients were randomised, with 90 in each arm.
03The primary outcome was death or severe disability at 6 months.

Application

Design takeaway

How to apply

When developing or assessing a new medical device or treatment protocol, design a study that includes both clinical outcome measures and an economic analysis to demonstrate its overall value.

Project actions

01When researching a medical device, consider its cost and how it compares to existing solutions.
02Think about the different ways to measure success for a medical intervention, not just survival rates.

Method & Evidence

AimTo determine the comparative effectiveness and cost-effectiveness of conventional ventilatory support versus extracorporeal membrane oxygenation (ECMO) for severe adult respiratory failure.

MethodRandomised controlled trial with parallel economic evaluation

ProcedurePatients with severe respiratory failure were randomised to either conventional management or consideration for ECMO. Outcomes measured included death or severe disability at 6 months, duration of ventilation, ICU stay, and hospital stay, alongside an economic evaluation.

Sample180 participants

ContextSevere adult respiratory failure in a hospital setting

Variables

IVTreatment type (Conventional Management vs. ECMO)

DVDeath or severe disability at 6 months, duration of ventilation, ICU stay, hospital stay

CVPatient age, severity of respiratory failure (Murray lung injury score or pH level), potentially reversible nature of respiratory failure

Strengths & Limitations

Strengths

+Multicentre randomised controlled trial design provides strong evidence.
+Inclusion of an economic evaluation alongside clinical outcomes offers a comprehensive assessment.

Limitations

It's hard to get enough patients for a trial like this, and the results might only apply to the specific hospitals where the study was done.

Reliability & validity

The randomised controlled trial design enhances internal validity by minimising bias. The multicentre nature may improve external validity, though specific patient populations and healthcare settings could still influence generalizability. Reliability would depend on consistent application of treatment protocols and outcome measurement across centres.

Think critically

How might the cost of ECMO influence its accessibility and adoption in different healthcare systems, and what design considerations could mitigate these cost barriers?

Design Principles

"Evaluate medical interventions based on both clinical outcomes and economic impact to ensure optimal resource allocation and patient benefit."

Understanding the trade-offs between advanced medical technologies like ECMO and standard treatments is crucial for resource allocation and patient outcomes. This research highlights the importance of rigorous comparative studies to inform clinical practice and healthcare policy, influencing the development and adoption of medical devices.

What This Means for Your Design

This study looked at whether a special breathing machine (ECMO) is better and cheaper than normal breathing support for very sick adults. It found that comparing treatments needs to look at how well patients do and how much it costs.

How to use in your project

1.Reference this study when discussing the importance of cost-effectiveness analysis in medical device design or when comparing different treatment options.

Add to My Project

Quick Cite

Paragraph starter

The CESAR trial (Peek et al., 2010) provides a robust example of how to evaluate complex medical interventions by integrating clinical effectiveness with economic analysis. This approach is crucial for understanding the true value of new technologies in healthcare settings, informing design decisions that balance patient outcomes with resource constraints.

Source

Health Technology Assessment

Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR)

journal · 2010

View source

Questions About This Research

What does the research say about ecmo vs. conventional ventilation: a cost-effectiveness analysis for severe respiratory failure?: When designing or evaluating medical interventions for critical conditions, consider a dual approach that assesses both clinical efficacy and economic viability to ensure the most beneficial and sustainable solutions. Evidence: Health Technology Assessment (2010).
Why does "ECMO vs. Conventional Ventilation: A Cost-Effectiveness Analysis for Severe Respiratory Failure" matter for design?: Understanding the trade-offs between advanced medical technologies like ECMO and standard treatments is crucial for resource allocation and patient outcomes. This research highlights the importance of rigorous comparative studies to inform clinical practice and healthcare policy, influencing the development and adoption of medical devices.
How can designers apply this research?: When designing or evaluating medical interventions for critical conditions, consider a dual approach that assesses both clinical efficacy and economic viability to ensure the most beneficial and sustainable solutions.
What were the main findings?: The study aimed to compare the effectiveness and cost-effectiveness of ECMO versus conventional ventilation for severe respiratory failure.. A total of 180 patients were randomised, with 90 in each arm.. The primary outcome was death or severe disability at 6 months.
What research method was used?: Randomised controlled trial with parallel economic evaluation with 180 participants.
How strong is the evidence?: Evidence strength is rated Moderate effect, based on a 2010 journal from Health Technology Assessment.
What should I do differently in my next project?: When developing or assessing a new medical device or treatment protocol, design a study that includes both clinical outcome measures and an economic analysis to demonstrate its overall value.
What are the limitations?: The study focused on a specific patient demographic (adults aged 18-65 with severe, potentially reversible respiratory failure) and was conducted at a single ECMO centre with referring hospitals, which may limit generalizability.